Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Brainimmune is Looking for a Strategic Partner to Advance the Neuroendocrine Immunology and Stress-Immunity Research Field
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
Norepinephrine through β2-adrenoceptor activation down-regulates pro-inflammatory pathogenic Th17 cells in a rodent model of rheumatoid arthritisMarch 20, 2018
Inhibitors of RORγt Targeting Th17 Cells May Hold Promising Therapeutic Potential in Inflammation & AutoimmunityJanuary 26, 2016
New Evidence that Peripheral Nerves Sense Infection and Drive IL-23 Production by Skin Dendritic CellsOctober 22, 2015
Pro-Inflammatory Th17 Cells and Glucocorticoid Resistance: Implications for Chronic Inflammatory Diseases and Their TreatmentMay 16, 2017
Th17 Cells and Lymphotoxin: Conductors for the Tertiary Lymphoid Tissues and Inflammation OrchestraJuly 1, 2016
The Th17–IL-17–IL-17R System Linked To Altered Brain Development and Autism-Like Symptoms in MiceMarch 3, 2016
Vasoactive Intestinal Peptide Inhibits Pathogenic Th17 Cells from Rheumatoid Arthritis PatientsMay 27, 2015
